Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels.
hepatocellular carcinoma
laparoscopic liver resection
long-term outcome
morbidity
repeat liver resection
repeat surgery
short-term outcome
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Jun 2021
25 Jun 2021
Historique:
received:
30
05
2021
revised:
17
06
2021
accepted:
21
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Less morbidity is considered among the advantages of laparoscopic liver resection (LLR) for HCC patients. However, our previous international, multi-institutional, propensity score-based study of emerging laparoscopic repeat liver resection (LRLR) failed to prove this advantage. We hypothesize that these results may be since the study included complex LRLR cases performed during the procedure's developing stage. To examine it, subgroup analysis based on propensity score were performed, defining the proximity of the tumors to major vessels as the indicator of complex cases. Among 1582 LRLR cases from 42 international high-volume liver surgery centers, 620 cases without the proximity to major vessels (more than 1 cm far from both first-second branches of Glissonian pedicles and major hepatic veins) were selected for this subgroup analysis. A propensity score matching (PSM) analysis was performed based on their patient characteristics, preoperative liver function, tumor characteristics and surgical procedures. One hundred and fifteen of each patient groups of LRLR and open repeat liver resection (ORLR) were earned, and the outcomes were compared. Backgrounds were well-balanced between LRLR and ORLR groups after matching. With comparable operation time and long-term outcome, less blood loss (283.3±823.0 vs. 603.5±664.9 mL,
Identifiants
pubmed: 34202373
pii: cancers13133187
doi: 10.3390/cancers13133187
pmc: PMC8268302
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Ann Surg. 2008 Sep;248(3):475-86
pubmed: 18791368
J Hepatobiliary Pancreat Sci. 2013 Jun;20(5):512-7
pubmed: 23404252
World J Surg. 2011 Mar;35(3):648-55
pubmed: 21184074
Surg Endosc. 2019 Jul;33(7):2083-2092
pubmed: 30887184
J Am Coll Surg. 2011 Feb;212(2):171-9
pubmed: 21276531
Br J Surg. 2019 May;106(6):783-789
pubmed: 30706451
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):711-20
pubmed: 25902703
Br J Surg. 2020 Jun;107(7):889-895
pubmed: 31994182
Surg Oncol. 2019 Mar;28:19-30
pubmed: 30851898
Ann Surg. 2009 Nov;250(5):831-41
pubmed: 19801936
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):721-7
pubmed: 26096910
World J Surg. 2017 Dec;41(12):3189-3198
pubmed: 28717911
J Hepatobiliary Pancreat Sci. 2015 May;22(5):342-52
pubmed: 25663288
J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):745-53
pubmed: 25242563
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
World J Gastroenterol. 2017 May 28;23(20):3581-3588
pubmed: 28611511
J Laparoendosc Adv Surg Tech A. 2017 Oct;27(10):1002-1008
pubmed: 28850285
Ann Surg. 2015 Apr;261(4):619-29
pubmed: 25742461
Surg Endosc. 2009 Aug;23(8):1807-11
pubmed: 19277781
World J Gastroenterol. 2014 Oct 21;20(39):14381-92
pubmed: 25339825
World J Hepatol. 2018 Jul 27;10(7):479-484
pubmed: 30079134
Surgery. 2007 May;141(5):589-97
pubmed: 17462458